Alta Partners this week announced the promotion of Alison de Bord to director. She joins six other Alta directors responsible for investing at Alta Partners. She currently represents Alta as a director on the boards of Aegerion Pharmaceuticals, Insulet, and SurgRx and was directly involved in Alta’s investments in Esperion Therapeutics and Kerberos Proximal Solutions.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.